-
Je něco špatně v tomto záznamu ?
The intra-articular pure-platelet rich plasma as a disease-modifying treatment for patients suffering from knee osteoarthritis
Waleed M. Jifeel, Ajil A. Alzamily, Ihsan Abdulabbas Alsalman
Jazyk angličtina Země Česko
Typ dokumentu klinická studie
Digitální knihovna NLK
Zdroj
NLK
ROAD: Directory of Open Access Scholarly Resources
od 2011
- MeSH
- artróza kolenních kloubů * terapie MeSH
- dospělí MeSH
- injekce intraartikulární MeSH
- lidé středního věku MeSH
- lidé MeSH
- plazma bohatá na destičky * MeSH
- statistika jako téma MeSH
- terapeutický index MeSH
- TNF-alfa analýza MeSH
- ukazatele zdravotního stavu MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- klinická studie MeSH
Background: The knee is the predominant weight-bearing joint affected by osteoarthritis, and knee osteoarthritis (KOA) is the 11th significant cause of disability. As life expectancy has increased, the need for knee replacement procedures has grown, putting a major financial burden on patients and healthcare systems. Intra-articular (IA) injection of platelet rich plasma (PRP) promises to be a potential method in research for the more preservative and biological strategies to treat this chronic degenerative condition. PRP has expected to contain a high number of growth factors and proteins involved in tissue repair mechanisms.Aim: This study aimed to determine the effect of intra-articular injections (IAIs) pure-PRP and their dosage regimen efficacy in patients with mild and moderate knee OA.Material and method: This study included 33 patients (11 male and 22 female). The patient groups included 16 with mild and 17 with moderate knee osteoarthritis. With ages ranged from 32 to 66 years old. These patients were divided into three groups based on dosage (12 received a single injection, 11 received a double injection, and 10 received a triple injection), with a two-week interval between injections. The outcome was measured using WOMAC index for pain, stiffness, and daily functional limitation, as well as laboratory testing for TNF-alpha using the Eliza technique. All the patients were assessed at baseline and after three months of injection. The study was designed as non-randomized controlled trial study during November 2021 to May 2022 at Al-imam Ali hospital, Babylon governorate, Iraq.Results: Regarding severity, In both mild and moderate knee osteoarthritis, serum TNF-alpha was significantly lower after treatment (p < 0.001). All WOMAC scores were showed significantly lower levels after treatment with pure-PRP as compared with their levels before treatment (p ≤ 0.001, Regarding the number of injections, all patients who received a single injection, double injections, and triple injections showed a significant decrease in the serum TNF-alpha and WOMAC scores (p 0.05) in both mild and moderate patients. The triple injections were more effective than double and single injections.Conclusions: In conclusion, the treatment with pure-PRP was safe and satisfactory for patients in terms of relieving clinical symptoms. The WOMAC scores has indicated that improvement in pain relief for patients after injection and could act as an anti-inflammatory, as inflammatory marker TNF-alpha was reduced after injection, and there was a superior outcome to increasing dose numbers, as triple injection gave a positive outcome in both mild and moderate KOA when compared to single and double injection.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23020013
- 003
- CZ-PrNML
- 005
- 20240129012300.0
- 007
- ta
- 008
- 240112s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.31482/mmsl.2022.049 $2 doi
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Jifeel, Waleed M. $u College of Medicine, University of AL-Qadisiyah, Iraq
- 245 14
- $a The intra-articular pure-platelet rich plasma as a disease-modifying treatment for patients suffering from knee osteoarthritis / $c Waleed M. Jifeel, Ajil A. Alzamily, Ihsan Abdulabbas Alsalman
- 504 __
- $a Literatura
- 520 9_
- $a Background: The knee is the predominant weight-bearing joint affected by osteoarthritis, and knee osteoarthritis (KOA) is the 11th significant cause of disability. As life expectancy has increased, the need for knee replacement procedures has grown, putting a major financial burden on patients and healthcare systems. Intra-articular (IA) injection of platelet rich plasma (PRP) promises to be a potential method in research for the more preservative and biological strategies to treat this chronic degenerative condition. PRP has expected to contain a high number of growth factors and proteins involved in tissue repair mechanisms.Aim: This study aimed to determine the effect of intra-articular injections (IAIs) pure-PRP and their dosage regimen efficacy in patients with mild and moderate knee OA.Material and method: This study included 33 patients (11 male and 22 female). The patient groups included 16 with mild and 17 with moderate knee osteoarthritis. With ages ranged from 32 to 66 years old. These patients were divided into three groups based on dosage (12 received a single injection, 11 received a double injection, and 10 received a triple injection), with a two-week interval between injections. The outcome was measured using WOMAC index for pain, stiffness, and daily functional limitation, as well as laboratory testing for TNF-alpha using the Eliza technique. All the patients were assessed at baseline and after three months of injection. The study was designed as non-randomized controlled trial study during November 2021 to May 2022 at Al-imam Ali hospital, Babylon governorate, Iraq.Results: Regarding severity, In both mild and moderate knee osteoarthritis, serum TNF-alpha was significantly lower after treatment (p < 0.001). All WOMAC scores were showed significantly lower levels after treatment with pure-PRP as compared with their levels before treatment (p ≤ 0.001, Regarding the number of injections, all patients who received a single injection, double injections, and triple injections showed a significant decrease in the serum TNF-alpha and WOMAC scores (p 0.05) in both mild and moderate patients. The triple injections were more effective than double and single injections.Conclusions: In conclusion, the treatment with pure-PRP was safe and satisfactory for patients in terms of relieving clinical symptoms. The WOMAC scores has indicated that improvement in pain relief for patients after injection and could act as an anti-inflammatory, as inflammatory marker TNF-alpha was reduced after injection, and there was a superior outcome to increasing dose numbers, as triple injection gave a positive outcome in both mild and moderate KOA when compared to single and double injection.
- 650 _7
- $a dospělí $7 D000328 $2 czmesh
- 650 _7
- $a ženské pohlaví $7 D005260 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 650 _7
- $a mužské pohlaví $7 D008297 $2 czmesh
- 650 _7
- $a lidé středního věku $7 D008875 $2 czmesh
- 650 17
- $a artróza kolenních kloubů $x terapie $7 D020370 $2 czmesh
- 650 17
- $a plazma bohatá na destičky $7 D053657 $2 czmesh
- 650 _7
- $a injekce intraartikulární $7 D007270 $2 czmesh
- 650 _7
- $a terapeutický index $7 D000076162 $2 czmesh
- 650 _7
- $a TNF-alfa $x analýza $7 D014409 $2 czmesh
- 650 _7
- $a statistika jako téma $7 D013223 $2 czmesh
- 650 _7
- $a ukazatele zdravotního stavu $7 D006305 $2 czmesh
- 655 _7
- $a klinická studie $7 D000068397 $2 czmesh
- 700 1_
- $a Alzamily, Ajil A. $u College of Medicine, University of AL-Qadisiyah, Iraq
- 700 1_
- $a Abdulabbas Alsalman, Ihsan $u College of Medicine, University of AL-Qadisiyah, Iraq
- 773 0_
- $t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 92, č. 4 (2023), s. 314-324 $w MED00011116
- 856 41
- $u https://mmsl.cz/artkey/mms-202304-0005_the-intra-articular-pure-platelet-rich-plasma-as-a-disease-modifying-treatment-for-patients-suffering-from-knee.php $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3 $c 1073 $y p $z 0
- 990 __
- $a 20231214 $b ABA008
- 991 __
- $a 20240129012250 $b ABA008
- 999 __
- $a ok $b bmc $g 2036205 $s 1206451
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2023 $b 92 $c 4 $d 314-324 $e 20231201 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
- LZP __
- $c NLK189 $d 20240129 $b NLK111 $a Actavia-MED00011116-20231214